These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 10080337)
41. Chronic inflammation from polycarbonate motility peg inhibits osteogenesis in a human hydroxyapatite orbital implant. Thakker MM; Zhang J; Sires BS Ophthalmic Plast Reconstr Surg; 2005 Sep; 21(5):399-401. PubMed ID: 16234714 [TBL] [Abstract][Full Text] [Related]
42. Osteogenesis with hematopoiesis simulating infection in a hydroxyapatite orbital implant. Jordan DR; Belliveau MJ; Brownstein S; Padmore RF Ophthalmic Plast Reconstr Surg; 2009; 25(1):72-4. PubMed ID: 19273939 [TBL] [Abstract][Full Text] [Related]
43. The influence of hyperbaric oxygen therapy and irradiation on hydroxyapatite ocular implant exposure and fibrovascular ingrowth in New Zealand white rabbits. DeBacker CM; Dutton JJ; Proia AD; Halperin EC; Wagle TN; Holck DE Ophthalmic Plast Reconstr Surg; 1999 Nov; 15(6):412-9. PubMed ID: 10588250 [TBL] [Abstract][Full Text] [Related]
44. Hydroxyapatite orbital implants. Experience with 100 cases. McNab A Aust N Z J Ophthalmol; 1995 May; 23(2):117-23. PubMed ID: 7546686 [TBL] [Abstract][Full Text] [Related]
45. [Complications of hydroxyapatite orbital implants in children: a series of 105 cases]. Lumbroso L; Levy C; Plancher C; Validire P; Asselain B; Doz F; Schlienger P; Desjardins L J Fr Ophtalmol; 2000 Mar; 23(3):249-54. PubMed ID: 10740051 [TBL] [Abstract][Full Text] [Related]
47. Primary placement of a hydroxyapatite-coated sleeve in bioceramic orbital implants. Liao SL; Shih MJ; Lin LL Am J Ophthalmol; 2005 Feb; 139(2):235-41. PubMed ID: 15733982 [TBL] [Abstract][Full Text] [Related]
48. Pyogenic granuloma as a presenting sign of hydroxyapatite orbital implant exposure: a clinicopathologic study. Owji N; Sadeghipour A; Salour H; Sahraeyan N Ophthalmic Plast Reconstr Surg; 2006; 22(6):467-71. PubMed ID: 17117104 [TBL] [Abstract][Full Text] [Related]
49. Integrated hydroxyapatite implant and non-integrated implants in enucleated Asian patients. Chuah CT; Chee SP; Fong KS; Por YM; Choo CT; Luu C; Seah LL Ann Acad Med Singap; 2004 Jul; 33(4):477-83. PubMed ID: 15329760 [TBL] [Abstract][Full Text] [Related]
50. Problems after evisceration surgery with porous orbital implants: experience with 86 patients. Jordan DR Ophthalmic Plast Reconstr Surg; 2004 Sep; 20(5):374-80. PubMed ID: 15377905 [TBL] [Abstract][Full Text] [Related]
51. Gadolinium-enhanced magnetic resonance imaging assessment of hydroxyapatite orbital implants. Spirnak JP; Nieves N; Hollsten DA; White WC; Betz TA Am J Ophthalmol; 1995 Apr; 119(4):431-40. PubMed ID: 7535979 [TBL] [Abstract][Full Text] [Related]
52. Bovine pericardium versus homologous sclera as a wrapping for hydroxyapatite orbital implants. Arat YO; Shetlar DJ; Boniuk M Ophthalmic Plast Reconstr Surg; 2003 May; 19(3):189-93. PubMed ID: 12918552 [TBL] [Abstract][Full Text] [Related]
53. Problems with the hydroxyapatite orbital implant: experience with 250 consecutive cases. Shields CL; Shields JA; De Potter P; Singh AD Br J Ophthalmol; 1994 Sep; 78(9):702-6. PubMed ID: 7947552 [TBL] [Abstract][Full Text] [Related]
54. [Biocompatibility of a porous alumina orbital implant. Preliminary results of an animal experiment]. Morel X; Rias A; Briat B; el Aouni A; D'Hermies F; Adenis JP; Legeais JM; Renard G J Fr Ophtalmol; 1998 Mar; 21(3):163-9. PubMed ID: 9759400 [TBL] [Abstract][Full Text] [Related]
55. Long-term outcomes of pegged and unpegged bioceramic orbital implants. Karslıoğlu S; Buttanrı IB; Fazıl K; Serin D; Akbaba M Ophthalmic Plast Reconstr Surg; 2012; 28(4):264-7. PubMed ID: 22785584 [TBL] [Abstract][Full Text] [Related]
59. A case of chronic infection 28 years after silicone orbital implant. Miyasaka M; Tanaka R; Hanai U; Yamazaki A; Iida M; Akamatsu T Tokai J Exp Clin Med; 2008 Apr; 33(1):35-8. PubMed ID: 21318962 [TBL] [Abstract][Full Text] [Related]